Literature DB >> 9291944

Dystrophic axonal swellings develop as a function of age and diabetes in human dorsal root ganglia.

R E Schmidt1, D Dorsey, C A Parvin, L N Beaudet, S B Plurad, K A Roth.   

Abstract

Neuroaxonal dystrophy, characterized by swollen axon terminals and, to a lesser degree, enlarged initial segments of axons or perikaryal projections, develops in human dorsal root sensory ganglia as a function of aging and diabetes. Lesions are typically located within the satellite cell capsule and are intimately applied to sensory neuronal perikarya, which are compressed and distorted but are otherwise normal. Swollen axons contain large numbers of neurofilaments that are immunoreactive with antisera to highly phosphorylated neurofilament epitopes but fail to stain with antisera directed against hypophosphorylated neurofilament epitopes. Other dystrophic swellings contain collections of tubulovesicular profiles admixed with neurotransmitter granules. Neuroaxonal dystrophy involves subpopulations of intraganglionic axons and apparent terminals, notably those containing CGRP, while apparently sparing others, including noradrenergic sympathetic axons. Diabetic subjects develop lesions prematurely and in greater numbers than in aged subjects. Individual dystrophic axons in diabetics and aged human subjects are identical in their light microscopic, immunohistochemical and ultrastructural appearance, suggesting the possibility of shared pathogenetic mechanisms.

Entities:  

Mesh:

Year:  1997        PMID: 9291944     DOI: 10.1097/00005072-199709000-00008

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  15 in total

1.  Mitochondrial stress and the pathogenesis of diabetic neuropathy.

Authors:  Paul Fernyhough; Subir K Roy Chowdhury; Robert E Schmidt
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01-01

Review 2.  Diabolical effects of rabies encephalitis.

Authors:  Alan C Jackson
Journal:  J Neurovirol       Date:  2015-05-21       Impact factor: 2.643

Review 3.  Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetes.

Authors:  Subir K Roy Chowdhury; Rick T Dobrowsky; Paul Fernyhough
Journal:  Mitochondrion       Date:  2011-07-02       Impact factor: 4.160

Review 4.  Mitochondrial dysfunction in diabetic neuropathy: a series of unfortunate metabolic events.

Authors:  Paul Fernyhough
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

5.  Role of oxidative stress in rabies virus infection of adult mouse dorsal root ganglion neurons.

Authors:  Alan C Jackson; Wafa Kammouni; Elena Zherebitskaya; Paul Fernyhough
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  Inherited neuroaxonal dystrophy in dogs causing lethal, fetal-onset motor system dysfunction and cerebellar hypoplasia.

Authors:  John C Fyfe; Raba' A Al-Tamimi; Rudy J Castellani; Diana Rosenstein; Daniel Goldowitz; Paula S Henthorn
Journal:  J Comp Neurol       Date:  2010-09-15       Impact factor: 3.215

7.  Abnormal centrifugal axons in streptozotocin-diabetic rat retinas.

Authors:  M J Gastinger; A J Barber; S A Khin; C S McRill; T W Gardner; D W Marshak
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

8.  4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy.

Authors:  Eli Akude; Elena Zherebitskaya; Subir K Roy Chowdhury; Kimberly Girling; Paul Fernyhough
Journal:  Neurotox Res       Date:  2009-06-26       Impact factor: 3.911

Review 9.  Abnormal calcium homeostasis in peripheral neuropathies.

Authors:  Paul Fernyhough; Nigel A Calcutt
Journal:  Cell Calcium       Date:  2009-12-24       Impact factor: 6.817

10.  Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress.

Authors:  Elena Zherebitskaya; Eli Akude; Darrell R Smith; Paul Fernyhough
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.